The value of ultrasound in detecting extra-axillary regional node involvement in patients with advanced breast cancer

Puneeth Iyengar, Eric A. Strom, Yu Jing Zhang, Gary J. Whitman, Benjamin D. Smith, Wendy A. Woodward, Tse Kuan Yu, Thomas A. Buchholz

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Assessment of the regional lymphatics is important for accurate staging and treatment of breast cancer patients. We sought to determine the role of regional ultrasound in providing clinically relevant information. We retrospectively analyzed data from patients who were treated curatively in 1996-2006 at The University of Texas MD Anderson Cancer Center for clinical stage III breast cancer. We compared differences in regional lymph node staging based on ultrasound versus mammography and physical examination in the 865 of 1,200 patients who had external-beam radiation as part of their treatment and regional ultrasound studies as part of their initial evaluation. Ultrasound uniquely identified additional lymph node involvement beyond the level I or II axilla in 37% of the patients (325 of 865), leading to a change in clinical nodal stage. Ninety-one percent of these abnormalities that could be biopsied (266 or 293) were confirmed to contain disease. The sites of additional regional nodal disease were: infraclavicular disease, 32% (275 of 865); supraclavicular disease, 16% (140 of 865); and internal mammary disease, 11% (98 of 865). All patients with involvement in the extra-axillary regional nodal basins received a radiation boost to the involved areas >10 Gy. Thus, over. one third of patients with advanced breast cancer had their radiation plan altered by the ultrasound findings. Regional ultrasound evaluation in patients with advanced breast cancer commonly revealed abnormalities within and beyond the axilla, which changed the clinical stage of disease and the radiation treatment strategy. Therefore, regional ultrasound is beneficial in the initial staging evaluation for such patients

Original languageEnglish (US)
Pages (from-to)1402-1408
Number of pages7
JournalOncologist
Volume17
Issue number11
DOIs
StatePublished - Nov 2012

Fingerprint

Breast Neoplasms
Radiation
Axilla
Lymph Nodes
Mammary Ultrasonography
Breast Diseases
Physical Examination
Therapeutics
Neoplasms

Keywords

  • Breast cancer
  • Locally advanced
  • Regional ultrasound
  • Staging

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Iyengar, P., Strom, E. A., Zhang, Y. J., Whitman, G. J., Smith, B. D., Woodward, W. A., ... Buchholz, T. A. (2012). The value of ultrasound in detecting extra-axillary regional node involvement in patients with advanced breast cancer. Oncologist, 17(11), 1402-1408. https://doi.org/10.1634/theoncologist.2012-0170

The value of ultrasound in detecting extra-axillary regional node involvement in patients with advanced breast cancer. / Iyengar, Puneeth; Strom, Eric A.; Zhang, Yu Jing; Whitman, Gary J.; Smith, Benjamin D.; Woodward, Wendy A.; Yu, Tse Kuan; Buchholz, Thomas A.

In: Oncologist, Vol. 17, No. 11, 11.2012, p. 1402-1408.

Research output: Contribution to journalArticle

Iyengar, P, Strom, EA, Zhang, YJ, Whitman, GJ, Smith, BD, Woodward, WA, Yu, TK & Buchholz, TA 2012, 'The value of ultrasound in detecting extra-axillary regional node involvement in patients with advanced breast cancer', Oncologist, vol. 17, no. 11, pp. 1402-1408. https://doi.org/10.1634/theoncologist.2012-0170
Iyengar, Puneeth ; Strom, Eric A. ; Zhang, Yu Jing ; Whitman, Gary J. ; Smith, Benjamin D. ; Woodward, Wendy A. ; Yu, Tse Kuan ; Buchholz, Thomas A. / The value of ultrasound in detecting extra-axillary regional node involvement in patients with advanced breast cancer. In: Oncologist. 2012 ; Vol. 17, No. 11. pp. 1402-1408.
@article{95902fd8dc4c4def92a2c6277856987a,
title = "The value of ultrasound in detecting extra-axillary regional node involvement in patients with advanced breast cancer",
abstract = "Assessment of the regional lymphatics is important for accurate staging and treatment of breast cancer patients. We sought to determine the role of regional ultrasound in providing clinically relevant information. We retrospectively analyzed data from patients who were treated curatively in 1996-2006 at The University of Texas MD Anderson Cancer Center for clinical stage III breast cancer. We compared differences in regional lymph node staging based on ultrasound versus mammography and physical examination in the 865 of 1,200 patients who had external-beam radiation as part of their treatment and regional ultrasound studies as part of their initial evaluation. Ultrasound uniquely identified additional lymph node involvement beyond the level I or II axilla in 37{\%} of the patients (325 of 865), leading to a change in clinical nodal stage. Ninety-one percent of these abnormalities that could be biopsied (266 or 293) were confirmed to contain disease. The sites of additional regional nodal disease were: infraclavicular disease, 32{\%} (275 of 865); supraclavicular disease, 16{\%} (140 of 865); and internal mammary disease, 11{\%} (98 of 865). All patients with involvement in the extra-axillary regional nodal basins received a radiation boost to the involved areas >10 Gy. Thus, over. one third of patients with advanced breast cancer had their radiation plan altered by the ultrasound findings. Regional ultrasound evaluation in patients with advanced breast cancer commonly revealed abnormalities within and beyond the axilla, which changed the clinical stage of disease and the radiation treatment strategy. Therefore, regional ultrasound is beneficial in the initial staging evaluation for such patients",
keywords = "Breast cancer, Locally advanced, Regional ultrasound, Staging",
author = "Puneeth Iyengar and Strom, {Eric A.} and Zhang, {Yu Jing} and Whitman, {Gary J.} and Smith, {Benjamin D.} and Woodward, {Wendy A.} and Yu, {Tse Kuan} and Buchholz, {Thomas A.}",
year = "2012",
month = "11",
doi = "10.1634/theoncologist.2012-0170",
language = "English (US)",
volume = "17",
pages = "1402--1408",
journal = "Oncologist",
issn = "1083-7159",
publisher = "AlphaMed Press",
number = "11",

}

TY - JOUR

T1 - The value of ultrasound in detecting extra-axillary regional node involvement in patients with advanced breast cancer

AU - Iyengar, Puneeth

AU - Strom, Eric A.

AU - Zhang, Yu Jing

AU - Whitman, Gary J.

AU - Smith, Benjamin D.

AU - Woodward, Wendy A.

AU - Yu, Tse Kuan

AU - Buchholz, Thomas A.

PY - 2012/11

Y1 - 2012/11

N2 - Assessment of the regional lymphatics is important for accurate staging and treatment of breast cancer patients. We sought to determine the role of regional ultrasound in providing clinically relevant information. We retrospectively analyzed data from patients who were treated curatively in 1996-2006 at The University of Texas MD Anderson Cancer Center for clinical stage III breast cancer. We compared differences in regional lymph node staging based on ultrasound versus mammography and physical examination in the 865 of 1,200 patients who had external-beam radiation as part of their treatment and regional ultrasound studies as part of their initial evaluation. Ultrasound uniquely identified additional lymph node involvement beyond the level I or II axilla in 37% of the patients (325 of 865), leading to a change in clinical nodal stage. Ninety-one percent of these abnormalities that could be biopsied (266 or 293) were confirmed to contain disease. The sites of additional regional nodal disease were: infraclavicular disease, 32% (275 of 865); supraclavicular disease, 16% (140 of 865); and internal mammary disease, 11% (98 of 865). All patients with involvement in the extra-axillary regional nodal basins received a radiation boost to the involved areas >10 Gy. Thus, over. one third of patients with advanced breast cancer had their radiation plan altered by the ultrasound findings. Regional ultrasound evaluation in patients with advanced breast cancer commonly revealed abnormalities within and beyond the axilla, which changed the clinical stage of disease and the radiation treatment strategy. Therefore, regional ultrasound is beneficial in the initial staging evaluation for such patients

AB - Assessment of the regional lymphatics is important for accurate staging and treatment of breast cancer patients. We sought to determine the role of regional ultrasound in providing clinically relevant information. We retrospectively analyzed data from patients who were treated curatively in 1996-2006 at The University of Texas MD Anderson Cancer Center for clinical stage III breast cancer. We compared differences in regional lymph node staging based on ultrasound versus mammography and physical examination in the 865 of 1,200 patients who had external-beam radiation as part of their treatment and regional ultrasound studies as part of their initial evaluation. Ultrasound uniquely identified additional lymph node involvement beyond the level I or II axilla in 37% of the patients (325 of 865), leading to a change in clinical nodal stage. Ninety-one percent of these abnormalities that could be biopsied (266 or 293) were confirmed to contain disease. The sites of additional regional nodal disease were: infraclavicular disease, 32% (275 of 865); supraclavicular disease, 16% (140 of 865); and internal mammary disease, 11% (98 of 865). All patients with involvement in the extra-axillary regional nodal basins received a radiation boost to the involved areas >10 Gy. Thus, over. one third of patients with advanced breast cancer had their radiation plan altered by the ultrasound findings. Regional ultrasound evaluation in patients with advanced breast cancer commonly revealed abnormalities within and beyond the axilla, which changed the clinical stage of disease and the radiation treatment strategy. Therefore, regional ultrasound is beneficial in the initial staging evaluation for such patients

KW - Breast cancer

KW - Locally advanced

KW - Regional ultrasound

KW - Staging

UR - http://www.scopus.com/inward/record.url?scp=84869405439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869405439&partnerID=8YFLogxK

U2 - 10.1634/theoncologist.2012-0170

DO - 10.1634/theoncologist.2012-0170

M3 - Article

VL - 17

SP - 1402

EP - 1408

JO - Oncologist

JF - Oncologist

SN - 1083-7159

IS - 11

ER -